Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

被引：0

作者：

Ashouri, Karam ^{[1
]}

Baca, Yasmine ^{[2
]}

Xiu, Joanne ^{[2
]}

Soni, Shivani ^{[1
]}

Algaze, Sandra ^{[1
]}

Jayachandran, Priya ^{[1
]}

Wong, Alexandra ^{[1
]}

Yang, Yan ^{[1
]}

Torres-Gonzalez, Lesly ^{[1
]}

Lo, Jae Ho ^{[1
]}

Zhang, Wu ^{[1
]}

Khushman, Moh'd M. ^{[3
]}

Weinberg, Benjamin Adam ^{[4
]}

Goel, Sanjay ^{[5
]}

Lou, Emil ^{[6
]}

Battaglin, Francesca ^{[1
]}

Lenz, Heinz-Josef ^{[1
]}

机构：

[1] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA USA

[2] Caris Life Sci, Phoenix, AZ USA

[3] Washington Univ St Louis, Siteman Canc Ctr, St Louis, MO USA

[4] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA

[5] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[6] Univ Minnesota, Minneapolis, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期

关键词：

281-5277-9249; 3282-4643-3735-2565; 283-237-267-6887-6888; 613-135-2370-7650-2700; 3282-3301-3439-2725-2676; 3282-270-9760; 283-2494; 5; 4; 3; 2; 38092-32477; 38092-32473; 38092-34303; 38092-33696; 38092-33099; 38092-32476; 38092-32475; 38092-32474; 38092-32472; 38092-32471; 38092-29187; 38092-26004; 38092-25821; 38092-25034; 38092-24919; 38092-24870; 38092-24312; 38092-21186; 38092-20124; 38092-20119; 38092-20072; 38092-18225; 38092-17484; 38092-17483; 38092-17482; 38092-17481; 1;

D O I：

10.1200/JCO.2024.42.3_suppl.699

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：699 / 699

页数：1

共 50 条

[1] Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Cao, Liwei
Huang, Chen
Zhou, Daniel Cui
Bathe, Oliver F.
Chan, Daniel W.
Hruban, Ralph H.
Ding, Li
Zhang, Bing
Zhang, Hui
CANCER RESEARCH, 2021, 81 (13)
[2] Proteogenomic characterizations of pancreatic ductal adenocarcinoma.
Cao, Liwei
Huang, Chen
Zhou, Daniel Cui
Hu, Yingwei
Lih, Mamie
Savage, Sara R.
Krug, Karsten
Clark, David J.
Schnaubelt, Michael
Chen, Lijun
Leprevost, Felipe Da Veiga
Eguez, Rodrigo Vargas
Nesvizhskii, Alexey I.
Mani, D. R.
Omenn, Gilbert S.
Boja, Emily S.
Mesri, Mehdi
Robles, Ana I.
Rodriguez, Henry
Bathe, Oliver F.
Chan, Daniel W.
Hruban, Ralph H.
Ding, Li
Zhang, Bing
Zhang, Hui
CANCER RESEARCH, 2021, 81 (22)
[3] Auranofin to prevent progression of pancreatic ductal adenocarcinoma.
Perez, Mayrim V. Rios
Roife, David
Dai, Bing Bing
Kang, Ya'an
Li, Xinqun
Pratt, Michael
Fleming, Jason B.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[4] Effect of metformin on survival in pancreatic ductal adenocarcinoma.
Amin, Sunil
Mhango, Grace
Lin, Jenny J.
Aronson, Anne
Boffetta, Paolo
Wisnivesky, Juan P.
Lucas, Aimee
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[5] Resolving and Targeting the Mechanobiome of Pancreatic Ductal Adenocarcinoma.
Surcel, A.
Zhu, Q.
Schiffhauer, E.
Anders, R. A.
Robinson, D. N.
MOLECULAR BIOLOGY OF THE CELL, 2015, 26
[6] A novel RAS inhibitor for pancreatic ductal adenocarcinoma.
Arshad, Tariq
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16263 - E16263
[7] Impact of site of metastases in pancreatic ductal adenocarcinoma.
Arshad, Adeel
Zhao, Songzhu
Wei, Lai
Stephens, Julie
Manne, Ashish
Noonan, Anne M.
Rahman, Shafia
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 708 - 708
[8] The tumor suppressor BAP1 regulates the Hippo pathway in pancreatic ductal adenocarcinoma.
Dey, Anwesha
CANCER RESEARCH, 2018, 78 (10) : 23 - 24
[9] Alteration of TGF-β signaling pathway predicts worse prognosis in pancreatic ductal adenocarcinoma.
Tian, Bole
Li, Mao
Cao, Dan
Li, Ang
Zhao, Xiaochen
Hou, Shengzhong
Lu, Shan
Mou, Yu
Liu, Xubao
Cai, Shangli
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[10] Targeting the sterol regulatory element-binding protein pathway in pancreatic ductal adenocarcinoma.
Myers, Stephanie
McGuire, Meredith
Shao, Wei
Liu, Chine
Ewachiw, Theodore
Rasheed, Zeshaan
Matsui, William
Sepalla, Toni
Burkhart, Richard
Espenshade, Peter
CANCER RESEARCH, 2021, 81 (22)

← 1 2 3 4 5 →